Haima Therapeutics is a biotechnology company that develops therapies for the treatment of bleeding and other blood-related ailments. It offers SynthoPlate, an injectable hemostatic agent that uses synthetic platelet technology to prevent bleeding after injuries, surgeries, thrombocytopenia, and rare bleeding disorders.